Invention Grant
- Patent Title: Antibody against mutant α-actinin-4
-
Application No.: US14343221Application Date: 2011-09-09
-
Publication No.: US09644026B2Publication Date: 2017-05-09
- Inventor: Shingo Shinagawa , Kazunari Ito , Yoshimi Tokashiki , Tomoaki Miyamoto , Kazufumi Honda , Tesshi Yamada
- Applicant: Shingo Shinagawa , Kazunari Ito , Yoshimi Tokashiki , Tomoaki Miyamoto , Kazufumi Honda , Tesshi Yamada
- Applicant Address: JP Fukuoka-Shi JP Tokyo
- Assignee: TRANS GENIC INC.,NATIONAL CANCER CENTER
- Current Assignee: TRANS GENIC INC.,NATIONAL CANCER CENTER
- Current Assignee Address: JP Fukuoka-Shi JP Tokyo
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/JP2011/071168 WO 20110909
- International Announcement: WO2013/035208 WO 20130314
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K16/30 ; C12N15/113 ; C12N5/16 ; G01N33/574
Abstract:
An antibody against mutant α-actinin-4 having an amino acid sequence with at least one amino acid residue substitution in the region between position 245 and 263 in the amino acid sequence of α-actinin-4, wherein the antibody recognizes all or a part of the substituted amino acid residue(s) in the region.
Public/Granted literature
- US20140248261A1 ANTIBODY AGAINST MUTANT ALPHA-ACTININ-4 Public/Granted day:2014-09-04
Information query
